European Society of Organ Transplantation Consensus Statement on Testing for Non-Invasive Diagnosis of Kidney Allograft Rejection

Other authors

Institut Català de la Salut

[Park S, Friedewald JJ] Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. [Sellares J, Bestard O] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Tinel C] Dijon University Hospital, INSERM UMR 1098 Right, UBFC, Dijon, France. [Anglicheau D] Necker Hospital, Assistance Publique-Hopitaux de Paris, INSERM U1151, Université Paris-Cité, Paris, France

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-02-14T09:51:45Z

2024-02-14T09:51:45Z

2024-01-04



Abstract

Biomarkers; Kidney transplant; Rejection


Biomarcadors; Trasplantament de ronyó; Rebuig


Biomarcadores; Transplante de riñón; Rechazo


To address the need for improved biomarkers for kidney transplant rejection, European Society of Organ Transplantation (ESOT) convened a dedicated working group comprised of experts in kidney transplant biomarkers to review literature pertaining to clinical and subclinical acute rejection to develop guidelines in the screening and diagnosis of acute rejection that were subsequently discussed and voted on during the Consensus Conference that took place in person in Prague. The findings and recommendations of the Working Group on Molecular Biomarkers of Kidney Transplant Rejection are presented in this article.

Document Type

Article


Published version

Language

English

Publisher

Frontiers Media

Related items

Transplant International;36

https://doi.org/10.3389/ti.2023.12115

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)